Hormone replacement therapy and mammographic screening

Clinical Radiology

Volumn 57, Issue 7, 2002, Pages 563-564

  Evans, A ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Mammography; Oestrogen replacement; Screening

Indexed keywords

ESTRADIOL; ESTROGEN; GESTAGEN; PROGESTERONE; TIBOLONE;

BREAST CANCER; CANCER RISK; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DRUG USE; ESTROGEN THERAPY; FEMALE; HEALTH PROGRAM; HORMONE SUBSTITUTION; HUMAN; MAMMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; SCREENING; SENSITIVITY AND SPECIFICITY;

EID: 0036665176     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1053/crad.2002.0940     Document Type: Review

References (16)

1. Cyrlak D, Wong CH. Mammographic changes in post menopausal women undergoing hormone replacement therapy. Am J Roentgenol 1993;161:1177-1183.
2. Doyle GJ, McLean L. Unilateral increase in mammographic density with hormone replacement therapy. Clin Radiol 1994;49: 50-51.
3. Persson I, Thurfjell E, Holmberg L. Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. J Clin Oncol 1997;15:3201-3207.
4. Marugg RC, van der Mooren MJ, Hendriks JH, Rolloand R Ruijs SH. Mammographic changes in postmenopausal women on hormone replacement therapy. Eur Radiology 1997;7:749-755.
5. Greendale GA, Reboussin BA, Sie A, et al. Effect of estrogen and estrogen-progestin on mammographic density. Ann Intern Med 1999;130:262-269.
6. Erel CT, Elter K, Akman C, et al. Mammographic changes in women receiving tibolone therapy. Fertil Steril 1998;69:970-875.
7. Rosenberg RD, Hunt WC, Williamson MR, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology 1998;209:511-518.
8. Seadour B, Esteve J, Heid P, Jacquemier J. Hormone replacement therapy and screening mammography: analysis of the results in the Bouche du Rhone programme. J Med Screen 1999;6:99-102.
9. Litherland JC, Stallard S, Hole D, Cordiner C. The effect of hormone replacement therapy on the sensitivity of screening mammograms. Clin Radiol 1999;54:285-288.
10. Kavanagh AM, Mitchell H, Giles GG. Hormone replacement therapy and accuracy of mammographic screening. Lancet 2000;355:270-274.
11. Cohen MEL. Effect of hormone replacement therapy on cancer detection by mammography [letter]. Lancet 1997;349:1624.
12. Thurfjell EL, Holmberg LH, Persson I. Screening mammography: sensitivity and specificity in relation to hormone replacement therapy. Radiology 1997;203:339-341.
13. Shelley JM, Smith AM, Dudley E, Dennerstein I. Use of hormone replacement therapy by Melbourne women. Aust NZ J Public Health 1995;19:387-392.
14. Harvey JA. Use and cost of breast imaging for postmenopausal women undergoing hormone replacement therapy. AJR Am J Roentgenol 1999;172:1615-1619.
15. Litherland JC, Evans AJ, Wilson ARM. The effect of hormone replacement therapy on recall rate in the National Health Breast Screening Programme. Clin Radiol 1997;52:276-279.
16. Harvey JA, Pinkerton JV, Herman CR. Short term cessation of hormone replacement therapy and improvement of mammographic specificity. J Natl Cancer Inst 1997;89:1623-1625.